Symbol | Exchange | Currency |
|---|
Investing.com - Elanco Animal Health (NYSE: ELAN) reported first quarter EPS of $0.45, $0.16 better than the analyst estimate of $0.29. Revenue for the quarter came in at $1.26B...
Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of nonregenerative anemia associated...
SPECIAL ALERT: The December episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Wednesday, December 9. Kevin Matras, Sheraz Mian, Jeremy...
The market was back to its record-setting ways on Tuesday, as three weeks’ worth of positive vaccine news has investors feeling pretty good about the future heading into...
Bayer (OTC:BAYRY) Aktiengesellschaft BAYRY announced the initiation of FINEARTS-HF, a placebo-controlled phase III study on finerenone. The study will investigate finerenone...
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its Farm Animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others.
| Average | 13.21 (+45.85% Upside) |
| High | 19.00 |
| Low | 8.50 |
| Price | 9.06 |
| No. of Analysts | 7 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Neutral | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 91.93 | 92.92 | 91.55 | -0.60 | -0.65% | 9.60M | NYSE | |||
| 122.87 | 124.29 | 122.42 | +0.20 | +0.16% | 20.05M | NASDAQ | |||
| 59.72 | 60.36 | 59.38 | +0.05 | +0.08% | 1.03M | NYSE | |||
| 63.89 | 66.08 | 63.34 | +0.87 | +1.38% | 3.10M | NYSE | |||
| 24.60 | 24.60 | 24.60 | -0.06 | -0.24% | 1.66K | NYSE | |||
| 22.45 | 22.47 | 22.42 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 24.56 | 24.56 | 24.56 | 0.00 | 0.00% | 312.00 | NYSE | |||
| 135.20 | 137.15 | 134.36 | +1.80 | +1.35% | 1.60M | NASDAQ | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 69.48 | 74.91 | 69.20 | +0.38 | +0.55% | 12.50M | NASDAQ | |||
| 2.40 | 2.43 | 2.365 | +0.030 | +1.27% | 2.02M | NASDAQ | |||
| 10.91 | 10.97 | 10.89 | -0.04 | -0.37% | 356.15K | NYSE | |||
| 1.59 | 1.68 | 1.57 | -0.030 | -1.85% | 120.52K | NASDAQ | |||
| 10.09 | 10.58 | 10.02 | +0.05 | +0.50% | 26.60M | NYSE | |||
| 56.00 | 56.40 | 54.15 | 0.00 | 0.00% | 0.00 | NASDAQ |